Independent monitors are your eyes and ears at the investigative clinical trial site. They need to have the clinical and scientific background to be your on-site representative and help you efficiently manage your project.
Some of the benefits of contracting with independent monitors include the ability to:
Independent monitors have significant depth of applicable experience that help make them highly-sought professional partners in the investigative clinical trial industry.
Rigor and Relationships
The Glaser Research Group uses thorough pre-screening processes with its monitors in order to build the strongest possible working relationships.
Glaser Research Group works with the monitors as needed throughout the life of each project. This oversight helps assure that all visits and reports occur in a timely, accurate and standardized manner according to corporate and sponsor SOPs.
All monthly visits within a project can be billed monthly on a single invoice, simplifying your record keeping and payment hassles.
Training and Support
To be a successful independent monitor requires continuous training and education. Glaser monitors are current and knowledgeable about the latest information and technologies in the sector.
Glaser Research Group provides trouble-shooting solutions for the problems and issue that arise. What that means to you is that you have a partner dedicated to not just filling a need gap on your project, but a partner dedicated to providing answers and solutions during the course of the project. It also means that the independent monitor has a support network available when needed.
Glaser Research Group provides monitors with specific indication and therapeutic experience to fit your project's needs. Our North American network means that we're connected with the unique and diverse skill sets to fit your project.
DENNIS C. GLASER, RPh, MBA
Dennis Glaser has immersed himself in the pharmaceutical and clinical trial industries for over twenty years.
His career experience includes:
Dennis Glaser has earned a national reputation for focusing on clear results for his clients. His customer-centric approach has established a confidence in his company's ability to navigate the complexities of clinical trials.